Our findings were corroborated by KEGG and protein-protein interaction network analysis, which presented FN1 as a hub gene in subcutaneous adipose tissue derived adipocyte of obese patients; consequently, FN1 and its associated signaling pathways could be rendered potential targets in treating obesity (Yu et al., 2022). The gene discussed is FN1; the disease is obesity disorder.